+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Metabolomics: Technologies and Global Markets

  • ID: 4752240
  • Report
  • February 2019
  • Region: Global
  • 222 Pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • Citoxlab
  • Exalenz Bioscience Ltd.
  • Leco Corp.
  • Metabolomx
  • MORE

Report Scope:

The main objective is to update market trends, market estimates, product offerings and technological advancements that occurred after that date and assess its growth potential over the five-year period from 2018 to 2023. The following are the key market estimation updates included in the current update version:

  • Analytical techniques have been divided into separation and detection techniques, with market estimates and forecasts provided at global and regional levels.
  • Separation techniques have been divided into liquid chromatography (specifically, high-performance liquid chromatography and ultra-performance liquid chromatography), gas chromatography and capillary electrophoresis. Market estimates at subsegment levels and regional levels are provided for all major segments mentioned above.
  • Detection techniques have been divided into mass spectrometry, multivariate analysis and spectroscopy techniques (which include nuclear magnetic resonance spectroscopy and Fourier transform infrared spectroscopy). Market estimates at subsegment levels and regional levels have been provided for all major segments mentioned above.
  • The estimates provided for the assays and bioinformatics segments have been updated to reflect current market trends. Additionally, market estimates and forecasts at global and regional levels are also included.
  • The current version of the report provides additional information regarding major application segments of metabolomics. On the basis of application areas, market estimates and forecasts are provided for biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics and other applications at global and regional levels.
  • New segments have been added to analyze the global metabolomics market on the basis of major indication areas. Additionally, on the basis of indication, estimates and forecasts are provided for cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism and others at global and regional levels in the current version.
  • In addition, a regional analysis has been provided for the global metabolomics market. In quantitative terms, additional market estimates and forecasts are provided for all products, application and indication segments at regional levels.

The report explores present and future strategies regarding metabolomics by understanding current market adoption and analyzing drivers in terms of scope (i.e., more applications) and maturity in terms of user adoption, collaboration with regulators and the emergence of standards.

This report highlights the main segments in the metabolomics market: assays, technological platforms required for metabolomic research, bioinformatic solutions essential for data processing and analysis, and the main applications of the metabolomic approach in different areas of industry. It discusses its major players and current and future trends and influences. Drivers and challenges in each subsegment of this industry are described in detail, including forecasts for the next five years.

This report also analyzes key marketed products, recent product launches and the regulatory landscape across different demographics. An overview is provided of the demographics of key regions, including North America, Europe, Asia-Pacific, Latin America and the Middle East. Potential growth at regional and country levels is also covered. The strategies of global companies engaged in the metabolomic space and profiles of top companies are covered.

Clinical biomarkers used in metabolomic research are not included in this report.

Report Includes:

  • 86 data tables and 16 additional tables
  • Brief overview and industry analysis of the global markets for metabolomics technologies
  • Analyses of global market trends with data from 2016 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and the Middle East
  • Examination of the main structure of the metabolomics market by segments, key application areas, and market participants
  • Market dynamics and estimated data regarding metabolomics by technological platforms (analytical instruments), detection techniques, separation techniques, assays, disease indication types, applications and geographical regions
  • Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
  • Detailed profiles of the leading companies in the metabolomics market, including LECO Corp., Metabolon Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • Citoxlab
  • Exalenz Bioscience Ltd.
  • Leco Corp.
  • Metabolomx
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Methodology and Information Sources
  • Secondary Research
  • Primary Research
  • Market Size Estimation
  • Data Triangulation
  • Geographic Breakdown
  • Analyst’s Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

  • Market Context for Metabolomics

Chapter 3 Overview of Metabolomics

  • Introduction
  • Metabolites
  • Metabolomics
  • Metabolomic History
  • Metabolic Pathways
  • Metabolomes
  • Large Bowel Microflora
  • Urine Metabolome
  • Food Metabolome
  • Lipidomes and Lipidomics
  • Fluxomics
  • Metabolomic Process Steps
  • Sample Preparation
  • Extraction
  • Derivatization
  • Separation and Detection
  • Data Analysis
  • Metabolomic Technology
  • Targeted and Untargeted Approaches
  • Applications

Chapter 4 Metabolomics Market Dynamics

  • Metabolomics Market Drivers
  • Increasing Investment in Metabolomic Research
  • Increase in Demand for Personalized Medicine
  • Increasing Pharmaceutical and Biotech R&D Spending
  • Technological Advancements
  • Increasing Use of Metabolomics in Toxicology Testing
  • Market Restraints
  • Complexity Associated with Data Examination and Processing
  • High Cost of Tools and Instruments
  • Key Market Opportunities
  • Rapid Growth Opportunities in Emerging Markets
  • Key Challenges
  • Complexity and Diversity of Biological Samples
  • Dearth of Skilled Researchers
  • Industry Insights
  • Market Trends

Chapter 5 Global Metabolomics Market Breakdown by Product

  • Introduction
  • Market Breakdown
  • Separation Techniques
  • Detection Techniques
  • Assays
  • Bioinformatics and Systems Biology Tools

Chapter 6 Global Metabolomics Market Breakdown by Indication

  • Introduction
  • Market Breakdown
  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism

Chapter 7 Global Metabolomics Market Breakdown by Application

  • Introduction
  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics

Chapter 8 Global Metabolomics Market Breakdown by Geography

  • Introduction
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Chapter 9 Competitive Analysis

  • Market Overview
  • Metabolomics Market Share Analysis
  • Product Portfolio Assessment
  • Competitive Situations and Trends

Chapter 10 Company Profiles

  • Abcam Plc
  • Agilent Technologies Inc.
  • BG Medicine Inc.
  • Bio-Rad Laboratories Inc.
  • Biocrates Ag
  • Biovision Inc.
  • Bruker Corp.
  • Calithera Biosciences Inc.
  • Chenomx
  • Citoxlab
  • Cleveland Heartlab Inc.
  • Cyprotex Plc (Part Of Evotec)
  • Danaher Corp.
  • Drumetix Laboratories Llc
  • Exalenz Bioscience Ltd.
  • Genomind, Inc.
  • Gerstel Gmbh & Co. Kg
  • Hepatochem
  • Human Metabolome Technologies America Inc.
  • Leco Corp.
  • Luminex Corp.
  • Merck Kgaa
  • Metabolomic Diagnostics
  • Metabolomic Technologies Inc.
  • Metabolomx
  • Metabolon Inc.
  • One Way Liver Genomics, S.L
  • Perkinelmer Inc.
  • Promega Corp.
  • Qiagen Gmbh
  • Shimadzu Corp.
  • Stemina Biomarker Discovery Inc.
  • Thermo Fisher Scientific Inc.
  • TSI Inc.
  • Waters Corp.

Chapter 11 Acronyms

List of Tables
Summary Table: Global Market for Metabolomics, by Product Type, Through 2023
Table 1: Publications Referencing Metabolomics, 2008-2018
Table 2: Human Metabolome Project and Database, 2015-2018
Table 3: Major Approaches in Metabolomics and their Advantages and Disadvantages
Table 4: Recent Funding Programs in Metabolomics
Table 5: Common Hyphenated Platforms in Metabolomic Research
Table 6: Global Market for Metabolomics, by Product Type, Through 2023
Table 7: Global Market for Metabolomics, by Region, Through 2023
Table 8: Global Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 9: Global Market for Separation Techniques Applied in Metabolomics, by Region, Through 2023
Table 10: Global Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 11: Global Market for Liquid Chromatography Applied in Metabolomics, by Region, Through 2023
Table 12: Global Market for High-Performance Liquid Chromatography Applied in Metabolomics, by Region, Through 2023
Table 13: Global Market for UPLC Applied in Metabolomics, by Region, Through 2023
Table 14: Global Market for Gas Chromatography Applied in Metabolomics, by Region, Through 2023
Table 15: Global Market for Capillary Electrophoresis Applied in Metabolomics, by Region, Through 2023
Table 16: Global Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 17: Global Market for Detection Techniques Applied in Metabolomics, by Region, Through 2023
Table 18: Leading Mass Spectroscopy Suppliers for the Life Sciences
Table 19: Leading Mass Spectroscopy Systems
Table 20: Global Market for Mass Spectrometry Applied in Metabolomics, by Region, Through 2023
Table 21: Global Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 22: Global Market for Spectroscopy Applied in Metabolomics, by Region, Through 2023
Table 23: Global Market for NMR Spectroscopy Applied in Metabolomics, by Region, Through 2023
Table 24: Global Market for Metabolomic Assays, by Product Type, Through 2023
Table 25: Global Market for Metabolomic Assays, by Region, Through 2023
Table 26: High-Content Screening Suppliers and Key Attributes
Table 27: Label-Free Technologies and Suppliers
Table 28: Major Categories of Assays Used in Metabolomics for Drug Discovery
Table 29: Assays Commonly Used with Metabolomic Assays
Table 30: In Vitro and In Vivo Assay Tests in Tier 1 Screening Battery
Table 31: Metabolomic Open-Access Data Processing Tools
Table 32: Metabolomic Public Resources
Table 33: Other Metabolomic Bioinformatic Resources
Table 34: Global Market for the Application of Bioinformatics in Metabolomics, by Region, Through 2023
Table 35: Global Market for Metabolomics, by Indication, Through 2023
Table 36: Global Market for the Application of Metabolomics in Cancer Indications, by Region, Through 2023
Table 37: Global Market for the Application of Metabolomics in Cardiovascular Disorders, by Region, Through 2023
Table 38: Representation of Pathways, Functions of Metabolites and Possible Biomarkers in Animal Model and Human-Based Studies of Various Neuropsychiatric Disorders
Table 39: Global Market for the Application of Metabolomics in Neurological Disorders, by Region, Through 2023
Table 40: Global Market for the Application of Metabolomics in Inborn Errors of Metabolism, by Region, Through 2023
Table 41: Global Market for Metabolomics, by Application, Through 2023
Table 42: Global Market for Biomarker Discovery, by Region, Through 2023
Table 43: Global Market for the Application of Metabolomics in Drug Discovery, by Region, Through 2023
Table 44: Global Market for the Application of Metabolomics in Toxicology Testing, by Region, Through 2023
Table 45: Global Market for the Application of Metabolomics in Nutrigenomics, by Region, Through 2023
Table 46: Global Market for the Application of Metabolomics in Functional Genomics, by Region, Through 2023
Table 47: Global Market for Metabolomics, by Region, Through 2023
Table 48: North American Market for Metabolomics, by Product Type, Through 2023
Table 49: North American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 50: North American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 51: North American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 52: North American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 53: North American Market for Metabolomics, by Indication, Through 2023
Table 54: North American Market for Metabolomics, by Application, Through 2023
Table 55: North American Market for Spectroscopy Applied in Metabolomic Assays, by Product Type, Through 2023
Table 56: European Market for Metabolomics, by Product Type, Through 2023
Table 57: European Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 58: European Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 59: European Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 60: European Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 61: European Market for Metabolomic Assays, by Product Type, Through 2023
Table 62: European Market for Metabolomics, by Indication, Through 2023
Table 63: European Market for Metabolomics, by Application, Through 2023
Table 64: Asia-Pacific Market for Metabolomics, by Product Type, Through 2023
Table 65: Asia-Pacific Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 66: Asia-Pacific Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 67: Asia-Pacific Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 68: Asia-Pacific Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 69: Asia-Pacific Market for Metabolomic Assays, by Product Type, Through 2023
Table 70: Asia-Pacific Market for Metabolomics, by Indication, Through 2023
Table 71: Asia-Pacific Market for Metabolomics, by Application, Through 2023
Table 72: Latin American Market for Metabolomics, by Product Type, Through 2023
Table 73: Latin American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 74: Latin American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 75: Latin American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 76: Latin American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 77: Latin American Market for Metabolomic Assays, by Product Type, Through 2023
Table 78: Latin American Market for Metabolomics, by Indication, Through 2023
Table 79: Latin American Market for Metabolomics, by Application, Through 2023
Table 80: Middle East and African Market for Metabolomics, by Product Type, Through 2023
Table 81: Middle East and African Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 82: Middle East and African Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 83: Middle-East and African Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 84: Middle East and African Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 85: Middle East and African Market for Metabolomic Assays, by Product Type, Through 2023
Table 86: Middle East and African Market for Metabolomics, by Indication, Through 2023
Table 87: Middle East and African Market for Metabolomics, by Application, Through 2023
Table 88: Manufacturers and Suppliers of Metabolomic Products, by Category, 2017
Table 89: Recent Developments in the Metabolomics Industry, January 2017 through December 2018
Table 90: Abcam Plc: Recent Financials, 2017 and 2018
Table 91: Agilent Technologies: Recent Financials, 2016 and 2017
Table 92: Bio-Rad Laboratories: Recent Financials, 2016 and 2017
Table 93: Bruker Corp.: Recent Financials, 2016 and 2017
Table 94: Calithera Biosciences: Recent Financials, 2016 and 2017
Table 95: Evotec: Recent Financials, 2016 and 2017
Table 96: Danaher Corp.: Recent Financials, 2016 and 2017
Table 97: Luminex Corp.: Recent Financials, 2016 and 2017
Table 98: Merck KGaA: Recent Financials, 2016 and 2017
Table 99: Qiagen N.V.: Recent Financials, 2016 and 2017
Table 100: Thermo Fisher Scientific: Recent Financials, 2016 and 2017
Table 101: Waters Corp.: Recent Financials, 2016 and 2017
Table 102: Important Acronyms Related to Metabolomics Used in This Report

List of Figures
Summary Figure: Global Market Share for Metabolomics, by Product Type, 2018 and 2023
Figure 1: Publications Referencing Metabolomics, 2008-2018
Figure 2: Cellular Respiration Stages
Figure 3: Factors Impacting Enzyme Activity
Figure 4: Typical Analytical Metabolomic Process Steps
Figure 5: Schematic Representation of a Metabolomic Workflow
Figure 6: Performance of Common Hyphenated MS Platforms
Figure 7: Bioinformatic Processes for Metabolomics
Figure 8: Cumulative Revenues of Biotechnology Companies, 2010-2017
Figure 9: Manufacturer and Supplier Market Share of Metabolomics, 2017
Figure 10: Abcam Plc: Recent Financials, 2017 and 2018
Figure 11: Abcam Plc: Revenue Share, by Product and Service, 2018
Figure 12: Abcam Plc: Revenue Share, by Region/Country, 2018
Figure 13: Agilent Technologies: Recent Financials, 2016 and 2017
Figure 14: Agilent Technologies: Revenue Share, by Business Segment, 2017
Figure 15: Agilent Technologies: Revenue Share, by Region/Country, 2017
Figure 16: Bio-Rad Laboratories: Recent Financials, 2016 and 2017
Figure 17: Bio-Rad Laboratories: Revenue Share, by Business Segment, 2017
Figure 18: Bio-Rad Laboratories: Revenue Share, by Region/Country, 2017
Figure 19: Bruker Corp.: Recent Financials, 2016 and 2017
Figure 20: Bruker Corp.: Revenue Share, by Business Segment, 2017
Figure 21: Bruker Corp.: Revenue Share, by Region/Country, 2017
Figure 22: Calithera Biosciences: Revenue Share and Financials, 2016 and 2017
Figure 23: Evotec: Recent Financials, 2016 and 2017
Figure 24: Evotec: Revenue Share, by Business Segment, 2017
Figure 25: Evotec: Revenue Share, by Region/Country, 2017
Figure 26: Danaher Corp.: Recent Financials, 2016 and 2017
Figure 27: Danaher Corp.: Revenue Share, by Business Segment, 2017
Figure 28: Danaher Corp.: Revenue Share, by Region/Country, 2017
Figure 29: Luminex Corp.: Recent Financials, 2016 and 2017
Figure 30: Luminex Corp.: Revenue Share, by Region/Country, 2017
Figure 31: Merck KGaA: Recent Financials, 2016 and 2017
Figure 32: Merck KGaA: Revenue Share, by Business Segment, 2017
Figure 33: Merck KGaA: Revenue Share, by Region, 2017
Figure 34: PerkinElmer: Revenue Share, by Business Segment, 2017
Figure 35: PerkinElmer: Revenue Share, by Region/Country, 2017
Figure 36: Qiagen N.V.: Recent Financials, 2016 and 2017
Figure 37: Qiagen N.V.: Revenue Share, by Segment, 2017
Figure 38: Qiagen N.V.: Revenue Share, by Region, 2017
Figure 39: Thermo Fisher Scientific: Recent Financials, 2016 and 2017
Figure 40: Thermo Fisher Scientific: Revenue Share, by Business Segment, 2017
Figure 41: Thermo Fisher Scientific: Revenue Share, by Region/Country, 2017
Figure 42: Waters Corp.: Recent Financials, 2016 and 2017
Figure 43: Waters Corp.: Revenue Share, by Business Segment, 2017
Figure 44: Waters Corp.: Revenue Share, by Region/Country, 2017

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abcam Plc
  • Agilent Technologies Inc.
  • BG Medicine Inc.
  • Bio-Rad Laboratories Inc.
  • Biocrates Ag
  • Biovision Inc.
  • Bruker Corp.
  • Calithera Biosciences Inc.
  • Chenomx
  • Citoxlab
  • Cleveland Heartlab Inc.
  • Cyprotex Plc (Part Of Evotec)
  • Danaher Corp.
  • Drumetix Laboratories Llc
  • Exalenz Bioscience Ltd.
  • Genomind, Inc.
  • Gerstel Gmbh & Co. Kg
  • Hepatochem
  • Human Metabolome Technologies America Inc.
  • Leco Corp.
  • Luminex Corp.
  • Merck Kgaa
  • Metabolomic Diagnostics
  • Metabolomic Technologies Inc.
  • Metabolomx
  • Metabolon Inc.
  • One Way Liver Genomics, S.L
  • Perkinelmer Inc.
  • Promega Corp.
  • Qiagen Gmbh
  • Shimadzu Corp.
  • Stemina Biomarker Discovery Inc.
  • Thermo Fisher Scientific Inc.
  • TSI Inc.
  • Waters Corp.
Note: Product cover images may vary from those shown
Adroll
adroll